Fiel, Milky Jane .
HRN: 12-73-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
LEVOFLOXACIN 500MG (TAB)
06/04/2025
06/11/2025
PO
500 MG/TAB
OD
KLEBSIELLA PNEUMONIAE INFECTION
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes